Loading candles…
Oxygenta Pharmaceutical Ltd, incorporated in 1990 in India, operates in the pharmaceutical industry focusing on manufacturing bulk drugs, active pharmaceutical ingredients (APIs), pharmaceutical preparations, organic fine chemicals, and intermediaries. The company is a subsidiary of Virupaksha Organics Limited and was formerly known as SS Organics Limited. It emphasizes quality-driven chemical processes in its operations. Its business segments include bulk drugs, API, pharmaceutical preparation, and organic fine chemicals.
This page is a live market overview for OXYGENTA PHARMACEUTICAL LIMITE (OXYGENTAPH) on the BSE. As a listed security, OXYGENTA PHARMACEUTICAL LIMITE is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for OXYGENTAPH before placing trades on tick2trade.
As of the latest feed, OXYGENTAPH last traded at ₹53.6 on BSE, up ₹1.79 (3.45%) from the previous close of ₹51.81. Today's session range is ₹52.4 – ₹54, against a 52-week band of ₹52.4 – ₹133.5. Traded volume today stands at 14.83K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for OXYGENTAPH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether OXYGENTAPH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for OXYGENTA PHARMACEUTICAL LIMITE before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in OXYGENTAPH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated OXYGENTAPH option chain page linked from this overview.
| Monthly F&O expiry |
| 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.